Target intelligence / Profile preview

Probable E3 SUMO-protein ligase RNF212 (RNF212)

Target
RNF212
Molecular classification
Enzyme, SUMO E3 ligase, Ubiquitin ligase (possible), RING finger protein, Other
01

Overview

Probable E3 SUMO-protein ligase RNF212 (RNF212) is an enzyme required for the regulation of crossing-over during meiosis, where it functions as a SUMO E3 ligase by stabilizing key meiotic recombination factors such as MSH4, MSH5, and TEX11[2][3]. RNF212 localizes to recombination sites, mediates the sumoylation of proteins involved in meiotic chromosome synapsis, and acts as a limiting factor for crossover designation, thus ensuring accurate genetic exchange and diversity[1][2][3]. Polymorphisms in RNF212 are associated with male infertility (Spermatogenic failure 62) and influence naturally occurring variation in recombination rates in humans[2][3]. This protein operates in concert with related factors such as HEI10 and RNF212B, with regulatory roles that are critical for pairing and exchange of genetic material between homologous chromosomes during gamete formation[1][2][3].

Other names
RING finger protein 212Probable E3 SUMO-protein transferase RNF212FLJ38841SPGF62ZHP3RNF212
02

Biological functions

Meiotic recombinationRegulation of crossing-overCoupling chromosome synapsis to recombinationStabilization of meiosis-specific recombination factorsProtein sumoylation
03

Disease associations

Male infertility (Spermatogenic failure 62)Recombination Rate Quantitative Trait Locus 1Other

Beyond the preview

Go deeper on Probable E3 SUMO-protein ligase RNF212 (RNF212).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Probable E3 SUMO-protein ligase RNF212 (RNF212).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call